$21.4M for Tandem Diabetes

5/29/09

Insulin pump developer Tandem Diabetes Care has raised $21.4 million in a $52.3 million financial round, according to a filing with the U.S. Securities and Exchange Commission. San Diego-based Tandem specializes in new insulin pump therapy technology. Last June, Tandem raised $13 million in a Series B round led by Domain Associates and Texas Pacific Growth.

    

Business, life sciences, and technology news — covering Boston, Seattle, San Diego, Detroit, San Francisco, New York and beyond.

© 2007-2012, Xconomy, Inc. Xconomy is a registered service mark of Xconomy, Inc. All rights reserved.

Site produced by Andrew Koyfman with design from Rob Hunter.